Neuroinflammation: Cause, Consequence, or Therapeutic Target in Chronic Neurodegeneration — A Perspective

Read full text Summarise with VIRAT
Authors: Rimsha Maqsood, Kainat Nawaz, Areeba Noor, Sumaika Kiran, Chashman Ahmed
Cited by: 0
References: 10

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Neuroinflammation — the sustained activation of central nervous system (CNS) innate and adaptive immune responses — is increasingly recognized as a central, yet complex, component of chronic neurodegenerative diseases (Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, Huntington’s disease). Rather than being purely reactive, inflammatory processes can precede clinical symptoms, interact bidirectionally with disease-specific proteinopathies, and alter disease trajectories. This Perspective synthesizes mechanistic and translational evidence supporting three non-mutually exclusive roles for neuroinflammation: (1) an upstream contributor to disease initiation; (2) an amplifier/consequence of ongoing neurodegeneration; and (3) a mutable therapeutic target whose success depends on timing, cellular specificity and patient stratification. We highlight key molecular mediators (inflammasomes, microglial and astrocytic phenotypes, innate immune receptors such as TREM2), summarize advances in imaging and fluid biomarkers, and propose a pragmatic roadmap for translating immunomodulatory strategies — from precision biomarker-guided trials to combinatorial therapies that preserve beneficial immune functions while limiting chronic toxicity.

Fields of Study & Subjects

Neuroinflammation and Neurodegeneration Mechanisms Inflammasome and immune disorders Neurological Disease Mechanisms and Treatments

Publication details

Journal / source
INNOVAPATH
Volume
2
Issue
1
Pages
4–4
Publication date
24 March 2026
Language
EN